Measurement of dopamine D2 receptors in living human brain using [11C]raclopride with ultra-high specific radioactivity

Nuclear Medicine and Biology

Volumn 37, Issue 7, 2010, Pages 831-835

  Fujimura, Yota ^a,b   Ito, Hiroshi ^a   Takahashi, Hidehiko ^a   Yasuno, Fumihiko ^a   Ikoma, Yoko ^a   Zhang, Ming Rong ^a   Nanko, Shinichiro ^b   Suzuki, Kazutoshi ^a   Suhara, Tetsuya ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

11C raclopride; Binding potential; Dopamine D2 receptor; Positron emission tomography; Ultra high specific radioactivity

Indexed keywords

DOPAMINE 2 RECEPTOR; RACLOPRIDE C 11; CARBON; DIAGNOSTIC AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; LIGAND; RACLOPRIDE;

ADULT; ARTICLE; BINDING AFFINITY; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DRUG BINDING SITE; DRUG DISTRIBUTION; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; HUMAN; LIGAND BINDING; MALE; MOLECULAR IMAGING; NEUROIMAGING; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PUTAMEN; RADIOSENSITIVITY; TEMPORAL CORTEX; THALAMUS; TISSUE DISTRIBUTION; BRAIN LEVEL; NUCLEAR MAGNETIC RESONANCE IMAGING;

ADULT; BRAIN CHEMISTRY; CARBON RADIOISOTOPES; DOPAMINE ANTAGONISTS; HUMANS; LIGANDS; MAGNETIC RESONANCE IMAGING; MALE; POSITRON-EMISSION TOMOGRAPHY; RACLOPRIDE; RECEPTORS, DOPAMINE D2; YOUNG ADULT;

EID: 77957012145     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2010.04.138     Document Type: Article

References (30)

1. Farde L., Ehrin E., Eriksson L., Greitz T., Hall H., Hedstrom C.G., et al. Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. Proc Natl Acad Sci U S A 1985, 82:3863-3867.
2. 2 receptor changes during the progression of early Parkinson's disease. Mov Disord 1993, 8:134-138.
3. 2 dopamine receptor binding in the living human brain by PET. Science 1986, 231:258-261.
4. 11C]raclopride binding and cognitive function in patients with depression. J Affect Disord 2006, 95:35-42.
5. 11C]raclopride PET study. Synapse 2006, 60:124-131.
6. 11C]raclopride. J Affect Disord 2006, 101:113-122.
7. Yasuno F., Suhara T., Okubo Y., Sudo Y., Inoue M., Ichimiya T., et al. Low dopamine d(2) receptor binding in subregions of the thalamus in schizophrenia. Am J Psychiatry 2004, 161:1016-1022.
8. 2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients. Biological Psychiatry 1993, 33:227-235.
9. 11C]raclopride is altered by drugs that modify synaptic dopamine levels. Synapse 1993, 13:350-356.
10. Dewey S.L., Smith G.S., Logan J., Brodie J.D., Simkowitz P., MacGregor R.R., et al. Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects. Proc Natl Acad Sci U S A 1993, 90:11816-11820.
11. 2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients. Psychopharmacology (Berl) 1997, 133:396-404.
12. 11C]FLB 457: re-evaluation of the validity of using a cerebellar reference region. J Cereb Blood Flow Metab 2007, 27:378-392.
13. 2 receptors using a very high-affinity ligand (FLB 457) and the multi-injection approach. J Cereb Blood Flow Metab 1999, 19:533-546.
14. 11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain. J Cereb Blood Flow Metab 1999, 19:1164-1173.
15. 11C]FLB 457 binding measured by PET. Synapse 2001, 41:87-95.
16. 11C]Ro15-4513 and its application in an extremely low concentration region to an ARG study. Nucl Med Biol 2003, 30:335-343.
17. 11C]compound to in vitro ARG. J Label Compd Radiopharm 2003, s240:46.
18. 11C]raclopride with ultrahigh specific activity in rat brain determined by homogenate assay and autoradiography. Nucl Med Biol 2008, 35:19-27.
19. Lammertsma A.A., Hume S.P. Simplified reference tissue model for PET receptor studies. Neuroimage 1996, 4:153-158.
20. 2 receptor density and affinity in the human brain measured by 3D PET. Int J Neuropsychopharmcol 1999, 2:73-82.
21. Mintun M.A., Raichle M.E., Kilbourn M.R., Wooten G.F., Welch M.J. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 1984, 15:217-227.
22. 2-dopamine receptors studied by PET - a comparison to the equilibrium analysis. J Cereb Blood Flow Metab 1989, 9:696-708.
23. 11C]raclopride binding. J Cereb Blood Flow Metab 1998, 18:941-950.
24. George S.R., Watanabe M., Di Paolo T., Falardeau P., Labrie F., Seeman P. The functional state of the dopamine receptor in the anterior pituitary is in the high affinity form. Endocrinology 1985, 117:690-697.
25. 2 dopamine receptors. Mol Cell Endocrinol 1984, 36:201-209.
26. 2 receptor binding sites for agonists. A tetrahedral model. Mol Pharmacol. 1985, 28:391-399.
27. Creese I., Sibley D.R., Leff S.E. Agonist interactions with dopamine receptors: focus on radioligand-binding studies. Fed Proc 1984, 43:2779-2784.
28. 11C]-(R)-2-CH3O-N-n-propylnorapomorphine in the human brain. J Nucl Med 2009, 50:703-710.
29. 11C]raclopride in healthy humans. Hum Brain Mapp 2008, 29:400-410.
30. 11C]raclopride in man. Synapse 1995, 20:200-208.